4//SEC Filing
STAPLETON RAYMOND D JR 4
Accession 0001457612-22-000034
CIK 0001457612other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:14 PM ET
Size
7.1 KB
Accession
0001457612-22-000034
Insider Transaction Report
Form 4
STAPLETON RAYMOND D JR
EVP PHARM SCI & MFG
Transactions
- Award
Common Stock
2022-03-15+43,750→ 46,250 total - Award
Stock Option (Right to Buy)
2022-03-15+131,250→ 131,250 totalExercise: $1.11Exp: 2032-03-15→ Common Stock (131,250 underlying)
Footnotes (2)
- [F1]Restricted stock units that represent the contingent right to receive, at settlement, one share of common stock. The restricted stock units are scheduled to vest 25% on each of the first four anniversaries of the grant date.
- [F2]The options are scheduled to vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.
Documents
Issuer
GENOCEA BIOSCIENCES, INC.
CIK 0001457612
Entity typeother
Related Parties
1- filerCIK 0001842805
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:14 PM ET
- Size
- 7.1 KB